Product Protocol: CDC73 antibody tested with human prostate carcinoma in immunohistochemistry (IHC) (OAAB05772)

Please go here to see the protocol used for Aviva’s CDC73 antibody (OAAB05772)

Product datasheet can be found here: CDC73 antibody (OAAB05772)

IHC information:
Formalin-fixed and paraffin-embedded human prostate carcinoma reacted with CDC73 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

Questions pertaining to this data can be directed to techsupport@avivasysbio.com

Aviva Systems Biology’s CDC73 antibody (OAAB05772) has been tested using other cell lysates and tissues. To obtain more data about this antibody, please email us at info@avivasysbio.com

To order by phone call us at (888) 880-0001, fax us at (858) 552-6975 or send an email to info@avivasysbio.com. Aviva manufactures this antibody so we can offer the best price. Please contact us to request pricing information.

All of Aviva’s products are guaranteed for the applications and experimental sample types mentioned. Are you curious if this product will work for you? Please contact us at techsupport@avivasysbio.com

This entry was posted in Immunohistochemistry Protocols and tagged , , . Bookmark the permalink.

Leave a Reply